Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
about
Low-dose rate brachytherapy for men with localized prostate cancerBiological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysisDo intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.Intra- and inter-radiation therapist reproducibility of daily isocenter verification using prostatic fiducial markers.Helical tomotherapy: an innovative technology and approach to radiation therapy.Estimation of α/β for late rectal toxicity based on RTOG 94-06Summary and recommendations of a National Cancer Institute workshop on issues limiting the clinical use of Monte Carlo dose calculation algorithms for megavoltage external beam radiation therapy.Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trialClinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.Intensity-modulated radiation therapy: emerging cancer treatment technology.Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy.Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects.Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.Emerging technologies in prostate cancer radiation therapy: improving the therapeutic window.Delineating the inner bladder surface using uniform contractions from the outer surface under variable bladder filling conditionsBreast cancer therapy-associated cardiovascular disease.A new fiducial marker for Image-guided radiotherapy of prostate cancer: clinical experience.Dosimetric correlation of acute and late toxicities in high-risk prostate cancer patients treated with three-dimensional conformal radiotherapy followed by intensity modulated radiotherapy boost.Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localizePreliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvementDosimetric evaluation of intensity modulated radiotherapy and 4-field 3-d conformal radiotherapy in prostate cancer treatment.Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis.Rectal planning risk volume correlation with acute and late toxicity in 3-dimensional conformal radiation therapy for prostate cancer.Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancer.Automatic CT simulation optimization for radiation therapy: A general strategy.Complications of curative radiation treatment for early prostate cancer.Improving IMRT delivery efficiency using intensity limits during inverse planning.A comparative study based on image quality and clinical task performance for CT reconstruction algorithms in radiotherapy.Automated detection of a prostate Ni-Ti stent in electronic portal images.Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy.Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy.Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer.Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study.Image‐guided helical tomotherapy for localized prostate cancer: technique and initial clinical observations.Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicitiesThe contribution of the cone beam Kv CT (CBKvCT) to the reduction in toxicity of prostate cancer treatment with external 3D radiotherapy
P2860
Q24235544-A7A776A9-C429-4CDA-A051-A17EBC0AE344Q24800137-3D53D9BB-4DA8-4882-9DC5-6AA40D1D2C2BQ34161145-1589BC08-BD71-4B26-A0AC-B95221D5EBA6Q34538532-72FAF39D-94D1-47FB-BF3B-605756634A34Q35081134-0099F57E-E6FB-4B5B-B249-BDAF34B267E9Q35186584-DEB94B7F-AD47-4296-B47B-A4F2621AE10AQ35624289-11A223C8-57CE-4B74-BC38-22B5E135FBC1Q35844052-EEFB517F-CB4B-44C4-A4D7-3A5DA47ABC75Q35992601-F278DAC1-74CE-476E-97D3-3526D52E2100Q36108702-E0282AB9-239D-4749-A787-DE6C6B299FAEQ36596640-D4AA5FB3-A6AE-466E-98E1-EE86F3B9EB3CQ36617012-45A7A4C7-AC16-461D-ABAE-0481B02D9638Q37480893-CEBC85AD-25B8-4F45-8C54-EE293880BDA4Q37601093-887A18F5-DC54-4E2A-8F54-864506635FAAQ37791392-FE3C4B4A-40D8-4EEE-9B22-CF9C9DAB24B4Q38269778-C8D41828-DECB-4B69-87FB-82864ACEBB57Q38645182-E945B018-B8F5-43C8-B6AA-44BC05D8D0CDQ39852963-0A8EBBE1-CA50-48FC-8710-67FBCDC3593EQ41907280-B76A9E09-A7C1-451B-85A2-D9D6DD4A066DQ41939804-3FD4680B-7C40-4C26-88E4-430FC4C6B87DQ41981580-033082E7-A2BD-4558-8CA1-323C1DB6032BQ42092328-F8B4B08D-402A-42F8-931C-632B4CF1EA42Q42100043-72375118-40F7-42C1-9BCC-BE5CA6FE40B9Q42319014-07D98B4D-1C93-44CA-BD4C-E7EB48B226FAQ43125022-9F7AE510-8560-421C-91B5-5F81C383F02FQ44057423-900A8FA5-2F51-4DB9-A7BF-BEA58E091EBDQ45957906-3B6D0D77-D8CC-48A7-ABC2-B2A429448B64Q46850619-0FD175B4-AA83-4AE4-BF55-89DA579A5BB1Q48237504-BC77012A-CA2E-424A-8C6A-29D2CB77005EQ48830512-A5F32BB0-4FBA-4EB6-9055-451CC046E0B4Q50604541-9E9DFFD4-D40F-4081-81C7-30B672BA6F81Q51071859-AC245801-41E1-4602-941A-1DE33D90A2EFQ51642053-A764368F-2C1C-4DAB-B704-EDE8FD737C49Q52053479-036BC66C-566B-461B-9BBC-FB114FF71F6FQ53162008-2380E7CE-B493-4BD4-B331-DC56CAA73F45Q53593229-135C1654-F16C-4EEC-ACA4-B233EC029769Q55191850-7CB26655-F710-48DF-A6C3-FCED4EFCECDFQ55563155-128C7438-DF13-4072-93FF-4240BED9F2C6Q57179181-7BE27791-FB47-4F86-9266-D5C4FE648D28Q58656934-84F2EFCB-70DC-4BE5-AC83-1C37E85EB532
P2860
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Preliminary report of toxicity ...... tate cancer on 3DOG/RTOG 9406.
@ast
Preliminary report of toxicity ...... tate cancer on 3DOG/RTOG 9406.
@en
type
label
Preliminary report of toxicity ...... tate cancer on 3DOG/RTOG 9406.
@ast
Preliminary report of toxicity ...... tate cancer on 3DOG/RTOG 9406.
@en
prefLabel
Preliminary report of toxicity ...... tate cancer on 3DOG/RTOG 9406.
@ast
Preliminary report of toxicity ...... tate cancer on 3DOG/RTOG 9406.
@en
P2093
P1476
Preliminary report of toxicity ...... tate cancer on 3DOG/RTOG 9406.
@en
P2093
Michalski JM
Roach M 3rd
Russell KJ
P304
P356
10.1016/S0360-3016(99)00443-5
P407
P577
2000-01-01T00:00:00Z